Home / Inspections / 1065149

FDA Inspection 1065149 — Catalent Greenville Inc

Catalent Greenville Inc — FEI 3000209735

The FDA completed an inspection of Catalent Greenville Inc on August 24, 2018 in Greenville, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
August 24, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Greenville, NC (United States)

Additional Details

Postmarket Adverse Drug Experience (PADE)

Facility

Other inspections at this facility

  • 1267356 (VAI Fri Oct 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1231042 (NAI Wed Jan 31 2024 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1097051 (VAI Fri Jul 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1019260 (NAI Thu Apr 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 983236 (NAI Thu Jul 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources